LAVERNE JONES: Open Payments
NPI 1255876298 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,929 in 18 payments from 13 companies in 2025. Trend: 2023 $1,399 · 2024 $1,502 · 2025 $1,929
Food & beverage: $1,929
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $515 |
| Eisai Inc. | 2 | $243 |
| Madrigal Pharmaceuticals | 1 | $140 |
| Astellas Pharma US Inc | 1 | $140 |
| Melinta Therapeutics, LLC | 1 | $121 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $120 |
| Paratek Pharmaceuticals, Inc. | 1 | $120 |
| Biogen, Inc. | 1 | $120 |
| Alnylam Pharmaceuticals Inc. | 1 | $119 |
| Exact Sciences Corporation | 1 | $117 |
Products named: KISUNLA, Leqembi, REZDIFFRA, Veozah, Rezzayo, CAPLYTA, NUZYRA, ZURZUVAE.
Industry payments across FL — which companies pay providers there.
